Parallax Health Sciences Inc (PRLX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1327 OCEAN AVENUE, SUITE M
SANTA MONICA, CA 90401
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 80 - Health Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments036391211
Cash and cash equivalent036391211
Receivables  448381,874  
Inventory, net of allowances, customer advances and progress billings   410831 ✕
Inventory   410831  
Other undisclosed current assets 9104132  
Total current assets:0551,4153,74911
Noncurrent Assets
Nontrade receivables    177 ✕
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 10391171016
Long-term investments and receivables  170170   
Accounts and financing receivable, after allowance for credit loss  170170   
Intangible asset, including goodwill, after accumulated amortization1,3643,0839774,0921820
Goodwill7857857853,888  
Intangible asset, excluding goodwill, after accumulated amortization5792,2981922041820
Deposits noncurrent assets   2323  
Other undisclosed noncurrent assets 22    
Total noncurrent assets:1,3643,2851,2094,4082735
TOTAL ASSETS:1,3643,3402,6248,1572836
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,6556,0273,9742,788303174
Interest and dividends payable4501,724804   
Taxes payable  3835   
Employee-related liabilities40236845   
Accounts payable8312,0211,458   
Accrued liabilities 2501,000    
Other undisclosed accounts payable and accrued liabilities7228761,6322,788303174
Debt1,317741  96 
Derivative instruments and hedges, liabilities24     
Due to related parties1,0051,284425134104922
Other undisclosed current liabilities1151311 99984
Total current liabilities:5,1168,0654,4102,9221,5011,180
Noncurrent Liabilities
Long-term debt and lease obligation93418,46413,69010,237  
Long-term debt, excluding current maturities93418,46413,69010,237  
Liabilities, other than long-term debt5251,1671,357   
Due to related parties4911,1671,357   
Derivative instruments and hedges, liabilities 34     
Other undisclosed noncurrent liabilities7403,03474096 190
Total noncurrent liabilities:2,19922,66515,78810,333 190
Total liabilities:7,31530,73020,19813,2541,5011,370
Equity
Equity, attributable to parent, including:(5,950)6,54617,68417,60714,87115,141
Preferred stock1111 1
Common stock158137107121 163
Common stock, share subscribed but unissued, subscriptions receivable    (0)(1) 
Common stock, value, subscriptions   (2)  ✕
Additional paid in capital13,0816,2462,2161,4961,394397
Deferred compensation equity (1,149)(1,810)    
Accumulated deficit(19,191)   (2,995)(1,894)
Warrants and rights outstanding  1,97215,36215,98916,47316,473
Stockholders' equity note, subscriptions receivable  (1)(2)✕✕✕
Other undisclosed equity, attributable to parent 1,149     
Other undisclosed equity  (33,935)(35,258)(22,704)(16,344)(16,475)
Total equity:(5,950)(27,390)(17,574)(5,097)(1,473)(1,334)
TOTAL LIABILITIES AND EQUITY:1,3643,3402,6248,1572836

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues123,19522,74911,580  
Revenue, net✕✕3,19522,74911,580  
Cost of revenue
(Cost of Product and Service Sold)		(20)(3,226)(19,188)(9,874)  
Gross profit:(9)(31)3,5611,705  
Operating expenses(6,626)(7,087)(6,708)(2,968)(851)(486)
Other undisclosed operating income (loss)     (8)12
Operating loss:(6,635)(7,118)(3,147)(1,262)(859)(473)
Nonoperating income (expense)22,243(6,758)(10,035)(2,458)(255)31
Debt instrument, convertible, beneficial conversion feature (28)   473 
Interest and debt expense22,858 918214247(21)
Income (loss) from continuing operations before income taxes:38,466(13,877)(12,264)(3,506)(867)(463)
Income tax expense  (3)(21)   
Other undisclosed income (loss) from continuing operations(22,858)     
Income (loss) from continuing operations:15,608(13,879)(12,285)(3,506)(867)(463)
Income (loss) before gain (loss) on sale of properties:14,784(12,925)(12,285)(3,506)(867)(463)
Income (loss) from discontinued operations (824)954    
Other undisclosed net income (loss) 824(951)(897)(214)(247)(42)
Net income (loss):15,608(13,877)(13,182)(3,720)(1,113)(504)
Other undisclosed net loss attributable to parent (824)     
Net income (loss) attributable to parent:14,784(13,877)(13,182)(3,720)(1,113)(504)
Preferred stock dividends and other adjustments      (33)
Other undisclosed net income available to common stockholders, basic      33
Net income (loss) available to common stockholders, diluted:14,784(13,877)(13,182)(3,720)(1,113)(504)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):15,608(13,877)(13,182)(3,720)(1,113)(504)
Comprehensive income (loss), net of tax, attributable to parent:15,608(13,877)(13,182)(3,720)(1,113)(504)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: